New paper: What can subpopulations tell us about rifampicin resistance? Philip Fowler, 14th October 202514th October 2025 Last Thursday this work which we’d previously preprinted looking at looking at rifampicin-resistant subpopulations in clinical M. tuberculosis samples was published in JAC-Antimicrobial Resistance. If you want to know more please read the blog post we wrote when it was preprinted. A nice touch, however, was that this was just in time for Viki Brunner to include in her thesis as she submitted it the following day! Share this: Share on X (Opens in new window) X Share on Bluesky (Opens in new window) Bluesky Email a link to a friend (Opens in new window) Email Share on LinkedIn (Opens in new window) LinkedIn Share on Mastodon (Opens in new window) Mastodon Related antimicrobial resistance clinical microbiology tuberculosis
I’m hiring! 26th June 20251st July 2025 Thanks to funding from the OxCoD4TB project, I am hiring a postdoctoral research associate. This… Share this: Share on X (Opens in new window) X Share on Bluesky (Opens in new window) Bluesky Email a link to a friend (Opens in new window) Email Share on LinkedIn (Opens in new window) LinkedIn Share on Mastodon (Opens in new window) Mastodon Read More
New grant: Ox4TB 17th March 202517th March 2025 Very pleased to announce that I am a co-investigator on the recently announced Oxford4TB project… Share this: Share on X (Opens in new window) X Share on Bluesky (Opens in new window) Bluesky Email a link to a friend (Opens in new window) Email Share on LinkedIn (Opens in new window) LinkedIn Share on Mastodon (Opens in new window) Mastodon Read More
clinical microbiology New paper: Addressing pandemic-wide systematic errors in the SARS-CoV-2 phylogeny 9th February 20269th February 2026 Zam Iqbal, at the University of Bath, led this epic study published today in Nature… Share this: Share on X (Opens in new window) X Share on Bluesky (Opens in new window) Bluesky Email a link to a friend (Opens in new window) Email Share on LinkedIn (Opens in new window) LinkedIn Share on Mastodon (Opens in new window) Mastodon Read More